EXHIBIT 99.1 Anika Reports Third Quarter 2025 Financial Results Commercial Channel revenue up 22% with continued strong Integrity Implant System and Hyalofast growth, and double-digit International OA Pain Management growth Third and final Hyalofast PMA module filed and data released Cingal achieved commercial milestone of more than one million injections worldwide since 2016 Reaffirming Fiscal 2025 guidance and long-term outlook and commencing a $15 million 10b5-1 share repurchase BEDFORD, Mass., Nov. 05, ...